Features
Ex Pfizer analyst talks to InPharm about his career
In-licensing from cutting edge biotech is now vital to pharma - but lower upfront payments are shifting the balance of risk and reward
Ben Adams reports on the NICE agency spreading the word on Health Technology Assessment around the world
Resignations and firings in top companies came thick and fast in 2011, exposing just how badly things can go wrong in the boardroom
Europe's economic crisis, massive fines for offences, and continued investment in emerging markets
An eventful year in which the market saw its fair share of promising treatments
Alex Blyth on how pharma industry marketers can acknowledge the ‘elephant in the room’ - and then eat it…
The Department of Health, foundation trusts, GPs and local councils all have a stake in the new system, reports Gavin Atkin
Brett Wells talks to John LaMattina, former head of global R&D at Pfizer, about his time at the pharma giant.
NICE's credit card bill shows the Institute maintains a frugal approach to spending
Mission Statement
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma jobs, pharma events, and pharma service company listings.
Site content is produced by our editorial team for InPharm.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
